一个案例报告 血交换 严重酒精性肝炎的急性慢性肝衰竭 失败的类固醇治疗
Nagarajan Venkatchocku Ashok Annamalai1, Garrett Kang2, Marianne Anastasia De Roza2
1National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore.
Case reports in gastroenterology
|October 9, 2025
概括
治疗性血交换 (TPE) 在酒精患者中显示出治疗急性至慢性肝衰竭 (ACLF) 的前景. 这种干预改善了肝移植不合格的患者的生存率,并减少了炎症反应.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 关键护理医学 关键护理医学
- 免疫学 免疫学 免疫学
背景情况:
- 急性至慢性肝衰竭 (ACLF) 携带高死亡率,通常是由过度活跃的炎症和免疫反应驱动的.
- 治疗性血交换 (TPE) 正在被探索为不适合肝移植的患者提供拯救生命的替代方案.
研究的目的:
- 评估治疗性血交换 (TPE) 在治疗严重酒精性急性至慢性肝衰竭 (ACLF) 的有效性.
主要方法:
- 介绍了一个56岁的男性,患有严重的酒精性肝硬化和ACLF的病例研究.
- 患者在初始抗生素和类固醇治疗无效后接受了三轮TPE治疗.
- 评估包括MELD评分,Maddrey区分函数 (MDF) 和Lille评分.
主要成果:
- 患者在TPE后表现出显著的临床和生化改善.
- 实现了放出和90天生存,表明TPE的积极影响.
- TPE有效降低了全身炎症和调节了免疫反应.
结论:
- 治疗性血交换 (TPE) 是面临高死亡风险的酒精ACLF患者可行的治疗选择.
- 鉴于器官稀缺和移植限制,TPE提供了一个关键的替代方案.
- 这种方法可以提高选择ACLF种群的生存率.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
212
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
212
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
188
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
188
Pleural Effusion II: Symptoms and Management
652
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
652
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy
176
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
176


